XPost: misc.news.internet.discuss   
   From: here@is.invalid   
      
   Major UK Trial Will Study Aspirin as a Covid-19 Treatment   
      
   A 120-year-old drug is about to be put to the test as a possible   
   treatment for covid-19. This week, researchers from the UK announced   
   they would start including aspirin as one of the treatments studied in   
   the ongoing RECOVERY trial--one of the largest and most influential   
   clinical trials conducted during the pandemic. They hope that   
   aspirin's well-known anti-clotting properties can help seriously ill   
   patients avoid death.   
   ...   
   ...   
   Many severe complications of covid-19 are thought to involve   
   blood-clotting problems. Some researchers have argued, and at least   
   one recent study has also suggested, that aspirin use could lead to   
   greater survival among covid-19 patients. But it usually takes data   
   from large-scale randomized and controlled clinical trials for doctors   
   to widely adopt a new treatment into their arsenal--data that RECOVERY   
   will hopefully provide.   
      
   "Aspirin is widely used to prevent blood clots in many other   
   conditions, including heart attack, stroke, and pre-eclampsia in   
   pregnant women," said Martin Landray, a researcher at the University   
   of Oxford and one of the project's lead scientists, in the   
   announcement of the new arm of the trial Friday. "But enrolling   
   patients in a randomised trial such as RECOVERY is the only way to   
   assess whether there are clear benefits for patients with covid-19 and   
   whether those benefits outweigh any potential side effects such as the   
   risk of bleeding."   
      
      
      
   --- SoupGate-Win32 v1.05   
    * Origin: you cannot sedate... all the things you hate (1:229/2)